PharVision Advisers’s American Express Global Business Travel GBTG Stock Holding History
Bought
Maintained
Sold
Other funds holding GBTG
AE
AMH
RCM
AM
AC
MAC
PharVision Advisers's GBTG Position: Q1 2026 in Review
PharVision Advisers sold out of American Express Global Business Travel (GBTG) in Q1 2026, closing a stake of 13,495 shares — an estimated $103K sold.
PharVision Advisers first reported a position in GBTG in Q1 2025 and held it in 4 quarters. The position peaked at $103K in Q4 2025. 169 funds tracked by Wall St. Rank hold GBTG as of Q1 2026.
- PharVision Advisers reported no remaining American Express Global Business Travel position as of Q1 2026 after selling out during the quarter.
- PharVision Advisers sold 13,495 American Express Global Business Travel shares in Q1 2026, an estimated $103K.
- PharVision Advisers first reported a position in American Express Global Business Travel in Q1 2025 and held it in 4 quarters.
- PharVision Advisers's American Express Global Business Travel position peaked at $103K in Q4 2025.
- 169 funds tracked by Wall St. Rank held American Express Global Business Travel as of Q1 2026.
Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.